Same Drug Class

Nivolumab vs Tamoxifen

Nivolumab vs Tamoxifen: Overview

This comparison examines the pharmacological differences between Nivolumab and Tamoxifen.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Tamoxifen: Selective estrogen receptor modulator (SERM).

Pharmacokinetics

Half-life: Nivolumab — 27 days; Tamoxifen — 5-7 days.

Chemical Properties

Molecular Formula: Tamoxifen — C26H29NO.

Molecular Weight: Tamoxifen — 371.5150 g/mol.

Type: Nivolumab — Antibody; Tamoxifen — Small molecule.